The North America Apheresis Market would witness market growth of 7.5% CAGR during the forecast period (2022-2028).
The key factors driving the apheresis market growth include increased demand for blood components globally and a surge in government blood donation initiatives. Furthermore, newly approved indications for apheresis treatment, such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus, contribute to market growth.
Good epidemiologic studies estimate of the prevalence (and incidence, where possible) of infectious markers in the general population, combined with an effective donor education, motivation, and recruitment policy to recruit new voluntary nonremunerated blood donors from these populations, is the key to recruiting and retaining safe blood donors. The retention of blood donors is influenced by a nice atmosphere in the blood bank, good donor care, and polite and effective interaction between personnel and donors.
The increasing number of diseases, an increase in the demand for blood and its elements and associated protection, technological development in the creation of new apheresis techniques, and increased reimbursement policy initiatives and financial support for apheresis procedures are all driving the growth of the apheresis market.
Apheresis is a technique that uses computerized machinery to remove a particular blood component from a patient. It is typically used to treat over 30 different disorders in Canada, and in 2002, over 7 million Canadian dollars was spent on 8600 plasma exchange treatments. The Canadian Apheresis Group (CAG) is a national volunteer organization of physicians and nurses who are interested in determining whether therapeutic apheresis should be used (TA).
It was established in 1980 under the auspices of the Department of National Health and Wellbeing with the objectives of providing a forum for information exchange among Canadian apheresis practitioners and continuing to develop statistically significant sound, evidence from clinical testings to test the efficacy of plasma exchange as a treatment for various disorders. Representatives from each of Canada's main medical centers are part of the organization, which serves as a link between the CAG and local hospital communities around the country.
The US market dominated the North America Apheresis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,083.4 million by 2028. The Canada market is experiencing a CAGR of 10% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 9% during (2022 - 2028).
Based on Procedure, the market is segmented into Donor/Automated and Therapeutic. Based on Product, the market is segmented into Disposable & Reagents, Devices, and Software. Based on Method, the market is segmented into Centrifugation, Membrane Separation, and Selective Adsorption. Based on End User, the market is segmented into Blood Centers, Hospitals, and Others. Based on Component, the market is segmented into Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or leukopheresis), Lymphocytes (Lymphopheresis or lymphapheresis), and RBC's (Erythropheresis). Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Apheresis Market is Estimated to reach $4 Billion by 2028, at a CAGR of 8.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Asahi Kasei Medical Co., Ltd., Kaneka Corporation, Cerus Corporation, B. Braun Melsungen AG, Nikkiso Co., Ltd., Charles River Laboratories International, Inc., and SB Kawasumi Laboratories, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Procedure
- Donor/Automated
- Therapeutic
By Product
- Disposable & Reagents
- Devices
- Software
By Method
- Centrifugation
- Membrane Separation
- Selective Adsorption
By End User
- Blood Centers
- Hospitals
- Others
By Component
- Plasma (Plasmapheresis)
- Platelets (Plateletpheresis)
- Leukocytes (Leukapheresis or leukopheresis)
- Lymphocytes (Lymphopheresis or lymphapheresis)
- RBC's (Erythropheresis)
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Haemonetics Corporation
- Fresenius SE & Co. KGaA
- Terumo Corporation
- Asahi Kasei Medical Co., Ltd
- Kaneka Corporation
- Cerus Corporation
- B.Braun Melsungen AG
- Nikkiso Co., Ltd
- Charles River Laboratories International, Inc.
- SB Kawasumi Laboratories, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Apheresis Market, by Procedure
1.4.2 North America Apheresis Market, by Product
1.4.3 North America Apheresis Market, by Method
1.4.4 North America Apheresis Market, by End User
1.4.5 North America Apheresis Market, by Country
1.4.6 North America Apheresis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Geographical Expansions
3.2.4 Approval and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Apheresis Market by Procedure
4.1 North America Donor/Automated Market by Country
4.2 North America Therapeutic Market by Country
Chapter 5. North America Apheresis Market by Product
5.1 North America Disposable & Reagents Market by Country
5.2 North America Devices Market by Country
5.3 North America Software Market by Country
Chapter 6. North America Apheresis Market by Method
6.1 North America Centrifugation Market by Country
6.2 North America Membrane Separation Market by Country
6.3 North America Selective Adsorption Market by Country
Chapter 7. North America Apheresis Market by End User
7.1 North America Blood Centers Market by Country
7.2 North America Hospitals Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Apheresis Market by Component
8.1 North America Plasma (Plasmapheresis) Market by Country
8.2 North America Platelets (Plateletpheresis) Market by Country
8.3 North America Leukocytes (Leukapheresis or leukopheresis) Market by Country
8.4 North America Lymphocytes (Lymphopheresis or lymphapheresis) Market by Country
8.5 North America RBC's (Erythropheresis) Market by Country
Chapter 9. North America Apheresis Market by Country
9.1 US Apheresis Market
9.1.1 US Apheresis Market by Procedure
9.1.2 US Apheresis Market by Product
9.1.3 US Apheresis Market by Method
9.1.4 US Apheresis Market by End User
9.1.5 US Apheresis Market by Component
9.2 Canada Apheresis Market
9.2.1 Canada Apheresis Market by Procedure
9.2.2 Canada Apheresis Market by Product
9.2.3 Canada Apheresis Market by Method
9.2.4 Canada Apheresis Market by End User
9.2.5 Canada Apheresis Market by Component
9.3 Mexico Apheresis Market
9.3.1 Mexico Apheresis Market by Procedure
9.3.2 Mexico Apheresis Market by Product
9.3.3 Mexico Apheresis Market by Method
9.3.4 Mexico Apheresis Market by End User
9.3.5 Mexico Apheresis Market by Component
9.4 Rest of North America Apheresis Market
9.4.1 Rest of North America Apheresis Market by Procedure
9.4.2 Rest of North America Apheresis Market by Product
9.4.3 Rest of North America Apheresis Market by Method
9.4.4 Rest of North America Apheresis Market by End User
9.4.5 Rest of North America Apheresis Market by Component
Chapter 10. Company Profiles
10.1 Fresenius SE & Co. KGaA
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers:
10.1.5.2 Geographical Expansions:
10.2 Terumo Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Partnerships, Collaborations, and Agreements:
10.2.4.2 Geographical Expansions:
10.2.4.3 Approvals and Trials:
10.3 Charles River Laboratories International, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Recent strategies and developments:
10.3.4.1 Acquisition and Mergers:
10.4 Haemonetics Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Approvals and Trials:
10.5 Asahi Kasei Medical Co., Ltd.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Acquisition and Mergers:
10.6 Kaneka Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.7 Cerus Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.8 B. Braun Melsungen AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.9 Nikkiso Co., Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental Analysis
10.9.4 Research & Development Expense
10.10. SB Kawasumi Laboratories, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
TABLE 1 North America Apheresis Market, 2018 - 2021, USD Million
TABLE 2 North America Apheresis Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Apheresis Market
TABLE 4 Acquisition and Mergers– Apheresis Market
TABLE 5 Geographical expansions - Apheresis Market
TABLE 6 Approvals and tials- Apheresis Market
TABLE 7 North America Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 8 North America Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 9 North America Donor/Automated Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Donor/Automated Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 14 North America Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 15 North America Disposable & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Disposable & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Devices Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Devices Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Software Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Software Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 22 North America Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 23 North America Centrifugation Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Centrifugation Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Membrane Separation Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Membrane Separation Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Selective Adsorption Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Selective Adsorption Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 30 North America Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 31 North America Blood Centers Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Blood Centers Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 38 North America Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 39 North America Plasma (Plasmapheresis) Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Plasma (Plasmapheresis) Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Platelets (Plateletpheresis) Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Platelets (Plateletpheresis) Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Leukocytes (Leukapheresis or leukopheresis) Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Leukocytes (Leukapheresis or leukopheresis) Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Lymphocytes (Lymphopheresis or lymphapheresis) Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Lymphocytes (Lymphopheresis or lymphapheresis) Market by Country, 2022 - 2028, USD Million
TABLE 47 North America RBC's (Erythropheresis) Market by Country, 2018 - 2021, USD Million
TABLE 48 North America RBC's (Erythropheresis) Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Apheresis Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Apheresis Market by Country, 2022 - 2028, USD Million
TABLE 51 US Apheresis Market, 2018 - 2021, USD Million
TABLE 52 US Apheresis Market, 2022 - 2028, USD Million
TABLE 53 US Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 54 US Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 55 US Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 56 US Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 57 US Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 58 US Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 59 US Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 60 US Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 61 US Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 62 US Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 63 Canada Apheresis Market, 2018 - 2021, USD Million
TABLE 64 Canada Apheresis Market, 2022 - 2028, USD Million
TABLE 65 Canada Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 66 Canada Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 67 Canada Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 68 Canada Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 69 Canada Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 70 Canada Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 71 Canada Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 72 Canada Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 73 Canada Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 74 Canada Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 75 Mexico Apheresis Market, 2018 - 2021, USD Million
TABLE 76 Mexico Apheresis Market, 2022 - 2028, USD Million
TABLE 77 Mexico Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 78 Mexico Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 79 Mexico Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 80 Mexico Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 81 Mexico Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 82 Mexico Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 83 Mexico Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 84 Mexico Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 85 Mexico Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 86 Mexico Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 87 Rest of North America Apheresis Market, 2018 - 2021, USD Million
TABLE 88 Rest of North America Apheresis Market, 2022 - 2028, USD Million
TABLE 89 Rest of North America Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 90 Rest of North America Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 91 Rest of North America Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 92 Rest of North America Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 93 Rest of North America Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 94 Rest of North America Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 95 Rest of North America Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 96 Rest of North America Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 97 Rest of North America Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 98 Rest of North America Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 99 key information – Fresenius SE & Co. KGaA
TABLE 100 Key Information – Terumo Corporation
TABLE 101 key information – Charles River Laboratories International, Inc.
TABLE 102 key information – Haemonetics Corporation
TABLE 103 Key Information – Asahi Kasei Medical Co., Ltd.
TABLE 104 Key Information – Kaneka Corporation
TABLE 105 key information – Cerus Corporation
TABLE 106 key Information – B. Braun Melsungen AG
TABLE 107 Key Information – Nikkiso Co., Ltd.
TABLE 108 Key Information – SB Kawasumi Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Fresenius SE & Co. KGaA
FIG 5 Recent strategies and developments: Terumo Corporation